Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00323258 · ClinicalTrials.gov registry record · NA
Study of an Intervention to Improve Use of Life-saving Medications for Heart Disease
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 143
- Enrollment target
NCT00323258: Completed NA study, sponsored by Duke University.
NCT00323258 is a NA study that has completed, run by Duke University. The registered enrollment target is 143 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00323258, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 143 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of a program to help patients with heart disease stay on their heart medications.
Primary Outcome
Percent of patients in each group adherent to triple therapy (aspirin/antiplatelet; beta blocker; and statin) 6 months after discharge as assessed by medication history obtained during a follow-up phone call by a blinded pharmacist
Interventions
- BEHAVIORAL oral education & written tips for remembering medications
- DEVICE pill box
- DEVICE pocket medication card
- BEHAVIORAL sharing information with community pharmacist
- BEHAVIORAL Medication use evaluations by community pharmacist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2006-06 |
| Est. Completion | 2011-03 |
| Phase | NA |
What the finished NCT00323258 record still lists
NCT00323258 is an interventional study that assigns participants to a tested intervention. The registered 143 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 5 interventions - of which oral education & written tips for remembering medications is the first listed.
NCT00323258 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00323258 about?
NCT00323258 is a clinical study titled "Study of an Intervention to Improve Use of Life-saving Medications for Heart Disease". The purpose of this study is to evaluate the effectiveness of a program to help patients with heart disease stay on their heart medications.
What is the current status of trial NCT00323258?
This trial is currently completed. It is a NA study. The enrollment target is 143 participants. The study started on 2006-06. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00323258?
The interventions under investigation include: oral education & written tips for remembering medications (BEHAVIORAL), pill box (DEVICE), pocket medication card (DEVICE), sharing information with community pharmacist (BEHAVIORAL), Medication use evaluations by community pharmacist (BEHAVIORAL).
Who is sponsoring clinical trial NCT00323258?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00323258's enrollment target sits among peer trials
143 711th of 2000 higher than 1,290 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia